Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Naresh Mandava

Concepts (378)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
24
2025
191
5.450
 Why?
Geographic Atrophy
14
2026
97
4.370
 Why?
Wet Macular Degeneration
8
2025
58
2.710
 Why?
Tomography, Optical Coherence
18
2025
271
2.540
 Why?
Visual Acuity
21
2025
489
2.170
 Why?
Fluorescein Angiography
20
2025
189
2.060
 Why?
Retinal Detachment
6
2023
73
1.910
 Why?
Diabetic Retinopathy
11
2023
208
1.700
 Why?
Retinal Drusen
4
2024
31
1.690
 Why?
Angiogenesis Inhibitors
17
2023
237
1.610
 Why?
Registries
9
2025
2385
1.540
 Why?
Choroid
7
2025
80
1.470
 Why?
Complement Activation
5
2025
411
1.190
 Why?
Vitreous Body
16
2022
117
1.100
 Why?
Vitrectomy
12
2020
73
1.010
 Why?
Multimodal Imaging
2
2025
129
0.980
 Why?
Macula Lutea
2
2023
21
0.960
 Why?
Vascular Endothelial Growth Factor A
13
2024
557
0.950
 Why?
Complement System Proteins
3
2025
316
0.900
 Why?
Retina
10
2021
324
0.810
 Why?
Aged, 80 and over
22
2025
8279
0.810
 Why?
Retinal Diseases
4
2023
101
0.760
 Why?
Antibodies, Monoclonal
9
2011
1524
0.730
 Why?
Biomarkers
8
2025
4275
0.720
 Why?
Retinal Neovascularization
2
2019
29
0.700
 Why?
Choroidal Neovascularization
6
2019
57
0.680
 Why?
National Eye Institute (U.S.)
1
2020
6
0.670
 Why?
Retinal Perforations
4
2015
18
0.650
 Why?
Aged
35
2025
25947
0.650
 Why?
Follow-Up Studies
17
2025
5417
0.640
 Why?
Quarantine
1
2020
31
0.630
 Why?
Estrogen Replacement Therapy
1
2019
144
0.570
 Why?
Retinitis Pigmentosa
3
2021
20
0.550
 Why?
Retinopathy of Prematurity
4
2024
179
0.550
 Why?
Fundus Oculi
8
2026
89
0.540
 Why?
Humans
87
2026
144957
0.500
 Why?
Epiretinal Membrane
3
2010
7
0.500
 Why?
Intraocular Pressure
6
2012
328
0.490
 Why?
Female
55
2025
78376
0.490
 Why?
Automobile Driving
1
2018
157
0.480
 Why?
Fovea Centralis
3
2025
24
0.480
 Why?
Male
53
2025
72406
0.470
 Why?
Scleral Buckling
3
2019
16
0.460
 Why?
Proliferating Cell Nuclear Antigen
2
2007
49
0.450
 Why?
Vitreoretinopathy, Proliferative
2
2007
15
0.450
 Why?
Optic Neuropathy, Ischemic
3
2013
31
0.420
 Why?
RNA, Catalytic
2
2007
189
0.420
 Why?
Self Report
1
2018
873
0.410
 Why?
Recombinant Fusion Proteins
4
2013
675
0.400
 Why?
Optic Disk
4
2025
53
0.390
 Why?
Antibodies, Monoclonal, Humanized
11
2015
988
0.390
 Why?
Middle Aged
34
2025
35928
0.390
 Why?
Surveys and Questionnaires
5
2025
6053
0.390
 Why?
Prospective Studies
9
2025
7997
0.380
 Why?
Research Design
1
2019
1137
0.370
 Why?
Bevacizumab
11
2015
167
0.370
 Why?
Retrospective Studies
26
2025
17101
0.360
 Why?
Retinal Necrosis Syndrome, Acute
2
2013
7
0.360
 Why?
Retinal Vein Occlusion
2
2015
14
0.360
 Why?
Image Processing, Computer-Assisted
3
2026
781
0.350
 Why?
Photography
4
2015
115
0.350
 Why?
Pandemics
1
2020
1695
0.350
 Why?
Retinal Pigment Epithelium
3
2024
80
0.340
 Why?
Uveal Diseases
2
2013
6
0.340
 Why?
Endophthalmitis
3
2017
45
0.340
 Why?
Disease Progression
6
2025
2852
0.330
 Why?
Colorado
8
2025
4564
0.330
 Why?
Cross-Sectional Studies
8
2025
5872
0.330
 Why?
Cataract
2
2020
238
0.330
 Why?
Diagnostic Techniques, Ophthalmological
2
2015
53
0.320
 Why?
Complement Factor B
2
2022
106
0.310
 Why?
Glycogen Storage Disease Type IIb
2
2007
27
0.310
 Why?
Visual Fields
3
2022
115
0.300
 Why?
Vision, Low
4
2022
17
0.300
 Why?
Pigment Epithelium of Eye
2
2006
36
0.290
 Why?
Injections
6
2010
197
0.290
 Why?
Ophthalmology
2
2013
116
0.280
 Why?
Ocular Hypertension
1
2009
70
0.270
 Why?
Risk Factors
11
2025
10792
0.270
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1416
0.270
 Why?
Phacoemulsification
3
2020
122
0.260
 Why?
Macular Edema
2
2015
49
0.260
 Why?
Encephalitis, Herpes Simplex
1
2007
21
0.260
 Why?
Optic Nerve Injuries
1
2007
9
0.260
 Why?
Quantum Dots
2
2021
39
0.260
 Why?
Glaucoma
3
2025
250
0.260
 Why?
von Hippel-Lindau Disease
1
2007
12
0.250
 Why?
Papilledema
1
2007
44
0.250
 Why?
Glucocorticoids
2
2013
535
0.250
 Why?
Vision Disorders
2
2022
178
0.250
 Why?
Puerperal Disorders
1
2007
37
0.250
 Why?
Triamcinolone Acetonide
1
2006
20
0.240
 Why?
Ocular Hypotension
1
2006
10
0.240
 Why?
Herpesvirus 1, Human
1
2007
84
0.240
 Why?
Ciliary Body
1
2006
40
0.230
 Why?
Myopia
1
2006
59
0.230
 Why?
Telangiectasis
1
2005
7
0.230
 Why?
Granuloma
1
2006
96
0.230
 Why?
Chemokine CCL5
2
2023
41
0.230
 Why?
Optical Imaging
1
2026
64
0.230
 Why?
Time Factors
5
2025
7183
0.220
 Why?
DNA, Viral
1
2007
358
0.220
 Why?
Retinal Vessels
1
2005
77
0.220
 Why?
Retinal Ganglion Cells
4
2022
121
0.210
 Why?
Diseases in Twins
1
2024
115
0.210
 Why?
Laser Therapy
2
2021
135
0.210
 Why?
Birth Weight
2
2024
522
0.200
 Why?
Diabetes Mellitus
2
2023
1098
0.200
 Why?
Vision Tests
1
2023
22
0.200
 Why?
Twins
1
2024
156
0.200
 Why?
Temporal Arteries
2
2015
43
0.200
 Why?
Fluorocarbons
1
2005
143
0.200
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2013
109
0.190
 Why?
Hemianopsia
1
2022
11
0.190
 Why?
Disease Models, Animal
4
2012
4569
0.180
 Why?
Ophthalmoscopy
2
2015
38
0.170
 Why?
Posterior Capsulotomy
1
2021
8
0.170
 Why?
Posterior Capsule of the Lens
1
2021
11
0.170
 Why?
Capsule Opacification
1
2021
22
0.170
 Why?
Lasers, Solid-State
1
2021
22
0.170
 Why?
Ranibizumab
5
2013
21
0.160
 Why?
Sickness Impact Profile
1
2020
62
0.160
 Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.160
 Why?
Artificial Intelligence
1
2025
367
0.160
 Why?
Herpesvirus 3, Human
2
2015
336
0.160
 Why?
Nerve Fibers
2
2010
104
0.160
 Why?
Reproducibility of Results
3
2025
3415
0.160
 Why?
Electrodes, Implanted
2
2018
115
0.150
 Why?
Neurodegenerative Diseases
1
2022
151
0.150
 Why?
Machine Learning
1
2026
587
0.150
 Why?
Intravitreal Injections
6
2020
71
0.150
 Why?
Protective Factors
1
2019
99
0.150
 Why?
Odds Ratio
2
2019
1077
0.150
 Why?
Complement Membrane Attack Complex
1
2019
38
0.150
 Why?
Ischemia
2
2017
421
0.150
 Why?
Complement C3a
1
2019
40
0.150
 Why?
C-Reactive Protein
1
2021
417
0.150
 Why?
Intraoperative Complications
1
2020
156
0.150
 Why?
Visual Prosthesis
1
2018
1
0.140
 Why?
Cohort Studies
5
2020
5965
0.140
 Why?
Metformin
1
2021
319
0.130
 Why?
Orbit
2
2010
64
0.130
 Why?
Anterior Eye Segment
1
2017
10
0.130
 Why?
Quality of Life
4
2022
3192
0.130
 Why?
Labor, Induced
1
2017
39
0.130
 Why?
Gestational Age
4
2024
975
0.130
 Why?
Labor, Obstetric
1
2017
66
0.120
 Why?
Giant Cell Arteritis
2
2015
46
0.120
 Why?
Postoperative Complications
3
2021
2920
0.120
 Why?
Strabismus
1
2017
71
0.120
 Why?
Laser Coagulation
3
2012
77
0.120
 Why?
Retinal Degeneration
2
2015
40
0.120
 Why?
Ophthalmologic Surgical Procedures
1
2017
90
0.120
 Why?
Blindness
3
2013
52
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.110
 Why?
Phenotype
3
2022
3164
0.110
 Why?
Recovery of Function
1
2019
710
0.110
 Why?
Immunosuppressive Agents
2
2013
847
0.110
 Why?
Vitreoretinal Surgery
1
2015
4
0.110
 Why?
Multivariate Analysis
1
2019
1540
0.110
 Why?
Case-Control Studies
2
2020
3608
0.110
 Why?
Vitreous Detachment
1
2015
6
0.110
 Why?
Needles
1
2015
62
0.110
 Why?
Incidence
2
2020
2883
0.110
 Why?
Encephalitis, Varicella Zoster
1
2015
16
0.110
 Why?
Eye Infections, Bacterial
1
2015
44
0.110
 Why?
Biopsy, Needle
1
2015
183
0.110
 Why?
Rats, Inbred BN
3
2011
55
0.110
 Why?
Antiviral Agents
2
2013
768
0.110
 Why?
Logistic Models
1
2019
2119
0.110
 Why?
Proteins
1
2020
1022
0.110
 Why?
Wounds, Gunshot
2
2010
258
0.100
 Why?
Treatment Outcome
7
2021
11695
0.100
 Why?
Inflammation
3
2023
2880
0.100
 Why?
Oculomotor Muscles
1
2014
84
0.100
 Why?
Anti-Inflammatory Agents
2
2021
475
0.100
 Why?
Drug Packaging
2
2011
41
0.100
 Why?
Uvea
1
2013
4
0.100
 Why?
Exchange Transfusion, Whole Blood
1
2013
19
0.100
 Why?
Uveomeningoencephalitic Syndrome
1
2013
8
0.100
 Why?
Retinal Artery Occlusion
1
2013
10
0.100
 Why?
Drug Resistance, Multiple, Viral
1
2013
10
0.100
 Why?
Fibrin
1
2014
91
0.100
 Why?
Tendons
1
2014
129
0.100
 Why?
Proteomics
1
2020
1195
0.100
 Why?
Cytomegalovirus Retinitis
1
2013
22
0.100
 Why?
Isoxazoles
1
2013
54
0.100
 Why?
Lymphoproliferative Disorders
1
2013
57
0.100
 Why?
Premature Birth
1
2017
380
0.100
 Why?
Fatty Acids, Omega-3
1
2014
142
0.090
 Why?
Silicon
1
2012
22
0.090
 Why?
Lens Subluxation
1
2012
4
0.090
 Why?
Trabecular Meshwork
1
2013
80
0.090
 Why?
Adult
15
2020
40506
0.090
 Why?
Viremia
1
2013
158
0.090
 Why?
Exanthema
1
2013
84
0.090
 Why?
Uveitis, Posterior
1
2012
12
0.090
 Why?
Diagnostic Imaging
1
2015
339
0.090
 Why?
Electric Stimulation Therapy
1
2012
63
0.090
 Why?
Fluocinolone Acetonide
1
2012
15
0.090
 Why?
Microsurgery
1
2012
72
0.090
 Why?
Diagnosis, Differential
4
2013
1495
0.090
 Why?
Placenta
1
2018
780
0.090
 Why?
Vascular Endothelial Growth Factors
1
2011
80
0.090
 Why?
Fluorescein-5-isothiocyanate
2
2009
36
0.080
 Why?
Electroretinography
2
2012
50
0.080
 Why?
Drug Storage
1
2011
53
0.080
 Why?
Dextrans
2
2009
86
0.080
 Why?
Silicone Oils
1
2011
34
0.080
 Why?
Global Health
1
2014
401
0.080
 Why?
Dissection
1
2011
56
0.080
 Why?
Particulate Matter
2
2011
347
0.080
 Why?
Health Care Costs
1
2014
427
0.080
 Why?
Antioxidants
1
2014
549
0.080
 Why?
Infliximab
2
2007
108
0.080
 Why?
Lysosomal-Associated Membrane Protein 2
2
2007
32
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
439
0.080
 Why?
Protein Multimerization
1
2011
214
0.080
 Why?
Clinical Trials, Phase II as Topic
1
2009
77
0.080
 Why?
Clinical Trials, Phase I as Topic
1
2009
52
0.080
 Why?
Anemia, Sickle Cell
1
2013
312
0.070
 Why?
Herpes Zoster
1
2013
315
0.070
 Why?
Tonometry, Ocular
1
2009
103
0.070
 Why?
Bacteria
1
2015
889
0.070
 Why?
Scotoma
1
2008
6
0.070
 Why?
Rats
4
2012
5614
0.070
 Why?
United States
3
2020
15988
0.070
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
254
0.070
 Why?
Algorithms
2
2026
1839
0.070
 Why?
Retinal Artery
1
2007
17
0.070
 Why?
Vitreous Hemorrhage
1
2007
10
0.070
 Why?
Cerebral Angiography
1
2007
119
0.060
 Why?
RNA, Messenger
2
2007
2832
0.060
 Why?
Acyclovir
1
2007
96
0.060
 Why?
Dose-Response Relationship, Drug
2
2009
2032
0.060
 Why?
Frameshift Mutation
1
2006
32
0.060
 Why?
Conjunctival Neoplasms
1
2005
7
0.060
 Why?
Ultrasonography
2
2007
770
0.060
 Why?
Internationality
2
2018
156
0.060
 Why?
Secondary Prevention
1
2007
255
0.060
 Why?
Eye Injuries, Penetrating
1
2005
19
0.060
 Why?
Indocyanine Green
1
2005
42
0.060
 Why?
Eye Foreign Bodies
1
2005
23
0.060
 Why?
beta-Thalassemia
1
2006
40
0.060
 Why?
Animals
7
2014
38109
0.060
 Why?
Coloring Agents
1
2005
93
0.060
 Why?
Eye Injuries
1
2006
53
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2007
1217
0.060
 Why?
Staining and Labeling
1
2005
151
0.060
 Why?
Uncertainty
1
2026
145
0.060
 Why?
Infant, Newborn
3
2024
6434
0.060
 Why?
Antihypertensive Agents
1
2009
511
0.060
 Why?
Uveitis
1
2006
148
0.050
 Why?
Mydriatics
1
2004
10
0.050
 Why?
Metals
1
2005
142
0.050
 Why?
Pupil
1
2004
22
0.050
 Why?
Pregnancy
3
2018
7191
0.050
 Why?
Polymerase Chain Reaction
1
2007
1054
0.050
 Why?
Sclera
2
2014
38
0.050
 Why?
Hospitals, County
1
2023
11
0.050
 Why?
Cardiomyopathy, Dilated
1
2007
359
0.050
 Why?
Image Interpretation, Computer-Assisted
1
2026
285
0.050
 Why?
Sensitivity and Specificity
2
2008
1990
0.050
 Why?
Observer Variation
1
2004
355
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
2
2019
851
0.050
 Why?
Fibroblasts
2
2013
1034
0.050
 Why?
Chimera
1
2002
61
0.050
 Why?
Enzyme Stability
1
2002
73
0.050
 Why?
Interleukin-4
1
2023
206
0.050
 Why?
Complement Factor I
1
2022
12
0.050
 Why?
Double-Blind Method
1
2007
2029
0.050
 Why?
Endopeptidases
1
2002
82
0.050
 Why?
Young Adult
6
2019
14126
0.050
 Why?
Preventive Medicine
1
2002
39
0.050
 Why?
Aqueous Humor
1
2022
38
0.050
 Why?
Blood
1
2002
109
0.050
 Why?
Autoimmune Diseases
1
2006
463
0.040
 Why?
Coculture Techniques
1
2002
246
0.040
 Why?
Albumins
1
2022
118
0.040
 Why?
Retreatment
2
2012
77
0.040
 Why?
Rabbits
1
2002
648
0.040
 Why?
Fibrinogen
1
2022
177
0.040
 Why?
Lenses, Intraocular
1
2021
49
0.040
 Why?
Cells, Cultured
2
2013
4155
0.040
 Why?
Cell Division
1
2002
766
0.040
 Why?
Equipment Design
2
2014
530
0.040
 Why?
Drug Compounding
2
2011
107
0.040
 Why?
Electric Stimulation
1
2021
276
0.040
 Why?
Immunologic Factors
1
2022
255
0.040
 Why?
Chronic Disease
1
2006
1813
0.040
 Why?
Cell Survival
2
2013
1098
0.040
 Why?
Melanoma
1
2005
761
0.040
 Why?
Postoperative Period
1
2019
354
0.040
 Why?
Immunity, Maternally-Acquired
1
2018
19
0.030
 Why?
Combined Modality Therapy
2
2013
1268
0.030
 Why?
Infant
3
2020
10039
0.030
 Why?
Primary Health Care
1
2008
1734
0.030
 Why?
Prevalence
2
2015
2836
0.030
 Why?
Lipids
1
2002
710
0.030
 Why?
Iris Diseases
1
2017
7
0.030
 Why?
Choroid Diseases
1
2017
10
0.030
 Why?
Longitudinal Studies
1
2025
2947
0.030
 Why?
Parity
1
2017
109
0.030
 Why?
Prosthesis Implantation
1
2018
153
0.030
 Why?
Infant, Low Birth Weight
1
2017
153
0.030
 Why?
Referral and Consultation
1
2022
853
0.030
 Why?
Sex Characteristics
1
2022
791
0.030
 Why?
Mental Health
1
2022
792
0.030
 Why?
Microbiological Techniques
1
2015
33
0.030
 Why?
Risk
1
2018
911
0.030
 Why?
Colony Count, Microbial
1
2015
122
0.030
 Why?
Endotamponade
1
2015
2
0.030
 Why?
Myopia, Degenerative
1
2015
5
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
34
0.030
 Why?
Cerebral Arterial Diseases
1
2015
49
0.030
 Why?
Conjunctiva
1
2014
53
0.030
 Why?
Biometry
1
2014
68
0.030
 Why?
Atrophy
1
2015
201
0.030
 Why?
Lens Implantation, Intraocular
1
2015
80
0.030
 Why?
Adolescent
3
2012
22453
0.030
 Why?
Fetus
1
2018
803
0.020
 Why?
T-Lymphocytes
1
2022
1982
0.020
 Why?
Early Diagnosis
1
2014
249
0.020
 Why?
Safety-net Providers
1
2014
126
0.020
 Why?
Adaptation, Ocular
1
2012
6
0.020
 Why?
Dark Adaptation
1
2012
13
0.020
 Why?
Rats, Mutant Strains
1
2012
20
0.020
 Why?
Sclerostomy
1
2012
4
0.020
 Why?
Infant, Premature
1
2017
611
0.020
 Why?
Cytomegalovirus
1
2013
168
0.020
 Why?
Child, Preschool
1
2007
11799
0.020
 Why?
Cell Count
1
2012
321
0.020
 Why?
Mothers
1
2018
775
0.020
 Why?
Drug Implants
1
2012
83
0.020
 Why?
Hypoglycemic Agents
1
2021
1389
0.020
 Why?
Gold
1
2012
116
0.020
 Why?
Bruch Membrane
1
2011
6
0.020
 Why?
Swine
1
2014
833
0.020
 Why?
Polyglycolic Acid
1
2011
44
0.020
 Why?
Miniaturization
1
2011
22
0.020
 Why?
Administration, Oral
1
2013
848
0.020
 Why?
Drug Stability
1
2011
164
0.020
 Why?
Delayed-Action Preparations
1
2011
183
0.020
 Why?
Chromatography, Gel
1
2010
131
0.020
 Why?
Immunoglobulin Light Chains
1
2010
51
0.020
 Why?
Fluorescein
1
2010
24
0.020
 Why?
Immunoglobulin Heavy Chains
1
2010
85
0.020
 Why?
Molecular Weight
1
2010
327
0.020
 Why?
Comorbidity
1
2015
1660
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2010
331
0.020
 Why?
Microfluidic Analytical Techniques
1
2010
81
0.020
 Why?
Aptamers, Nucleotide
1
2010
85
0.020
 Why?
Lactic Acid
1
2011
302
0.020
 Why?
Particle Size
1
2011
411
0.020
 Why?
Reference Values
1
2010
798
0.020
 Why?
Poverty Areas
1
2008
42
0.020
 Why?
Community Health Centers
1
2008
59
0.020
 Why?
Fluorescent Dyes
1
2010
330
0.020
 Why?
Optic Nerve Diseases
1
2008
49
0.020
 Why?
Kaplan-Meier Estimate
1
2010
966
0.020
 Why?
Models, Biological
1
2015
1822
0.020
 Why?
Kidney Transplantation
1
2013
704
0.020
 Why?
Pilot Projects
1
2012
1890
0.010
 Why?
Polyethylene Glycols
1
2011
655
0.010
 Why?
Imaging, Three-Dimensional
1
2010
583
0.010
 Why?
Pedigree
1
2007
514
0.010
 Why?
Infusions, Intravenous
1
2006
423
0.010
 Why?
Adrenal Cortex Hormones
1
2008
479
0.010
 Why?
Anti-Bacterial Agents
1
2015
1915
0.010
 Why?
Severity of Illness Index
1
2011
2925
0.010
 Why?
Mass Screening
1
2008
1348
0.010
 Why?
Tomography, X-Ray Computed
1
2010
2738
0.010
 Why?
Risk Assessment
1
2008
3676
0.010
 Why?
Diabetes Mellitus, Type 2
1
2012
2584
0.010
 Why?
Aging
1
2008
1966
0.010
 Why?
Mutation
1
2007
4099
0.010
 Why?
Child
1
2012
22657
0.010
 Why?
Mandava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (378) concept(s)
_
Co-Authors Expand Description
See all (53) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)